BackSYBLEU Overview

SYBLEU EBIT

SYBLEU's EBIT is $-300K, below the Healthcare sector average of $1.9T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$20.48K
↓ 310.28% YoY

As of Dec 31, 2023

Annual EBIT (TTM)

-$295.81K

Trailing 12 months ending Dec 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

SYBLEU (SYBE) FAQ

The latest EBIT for SYBE is $-300K as of December 2023. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside SYBLEU's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, SYBE currently prints $-300K for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at SYBLEU's growth, margins, and balance sheet.

A EBIT figure of $-300K for SYBE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.

After noting SYBE's EBIT ($-300K), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack SYBLEU's EBIT against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.